Peregrine Shares Continue to Bleed, Sticking Around Could Hurt Worse
Most Popular - By David Moskowitz Peregrine Pharmaceuticals (NASDAQ:PPHM) opened down in early trading, as investors are still getting over the shock of the favorable clinical trial results … Continue Reading
Read now